Stifel Initiates Coverage On ClearPoint Neuro with Buy Rating, Announces Price Target of $8
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Mathew Blackman has initiated coverage on ClearPoint Neuro (NASDAQ:CLPT) with a Buy rating and a price target of $8.
October 24, 2023 | 8:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ClearPoint Neuro has been initiated with a Buy rating by Stifel with a price target of $8.
The initiation of coverage by Stifel with a Buy rating and a price target of $8 indicates a positive outlook for ClearPoint Neuro. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100